LACEY QUARLES: Open Payments
NPI 1336207372 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 80 payments from 20 companies in 2025. Trend: 2023 $1,997 · 2024 $1,253 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $219 |
| Amgen Inc. | 15 | $196 |
| Novo Nordisk Inc | 10 | $154 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| Corium, LLC | 6 | $112 |
| TOLMAR, INC. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| PFIZER INC. | 3 | $57 |
| Antares Pharma, Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
Products named: MOUNJARO, AIRSUPRA, Azstarys, KRYSTEXXA, Wegovy, OTEZLA, Ozempic, JATENZO.
Industry payments across AL — which companies pay providers there.
